Company intelligence / Profile preview
Johnlee Pharmaceuticals
Mumbai, Maharashtra, Indiajohnleeindia.com ↗
- Ownership
- Private
- Employees
- ~57
- Development stage
- Other
01
Overview
Johnlee Pharmaceuticals offers more than 1000 pharmaceutical formulations—many already commercially available—in diverse therapeutic areas, and is developing next-generation proteasome inhibitors aimed at oncology, although no clinical results for the latter are published.
- Therapeutic areas
- EndocrinologyRheumatologyMetabolic DisordersPsychiatryInfectious DiseasesGastroenterologyPulmonologyDermatologyCardiovascular
- Modalities
- Small moleculeBiologicVaccine
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Commercial network of agents worldwide (no major pharma named)
Beyond the preview
Go deeper on Johnlee Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Johnlee Pharmaceuticals.